Package leaflet: Information for the user Repatha 140 mg solution for injection in pre-filled pen evolocumab Read all of this le
Instructions for Use Repatha® (ri-PAth-a) (evolocumab) injection, for subcutaneous use Single-Dose Prefilled SureClick® Autoin
Patient Information REPATHA® (ri-PAth-a) (evolocumab) injection, for subcutaneous use What is REPATHA? REPATHA is an injectable
![Amgen's Repatha gains an edge on rival Praluent with FDA approval to treat children with rare cholesterol condition | Fierce Pharma Amgen's Repatha gains an edge on rival Praluent with FDA approval to treat children with rare cholesterol condition | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1632751130/Repatha_0.png/Repatha_0.png?VersionId=ji8BkjbdCRGoN1r3B6i16PPSoLcfl.Eq)
Amgen's Repatha gains an edge on rival Praluent with FDA approval to treat children with rare cholesterol condition | Fierce Pharma
![Repatha (evolocumab) for the Treatment of Heterozygous and Homozygous Familial Hypercholesterolaemia - Clinical Trials Arena Repatha (evolocumab) for the Treatment of Heterozygous and Homozygous Familial Hypercholesterolaemia - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2015/09/Image-3-Repatha-evolocumab.jpg)